| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 07/31/2007 | US7250516 Phenylalanine derivatives |
| 07/31/2007 | US7250513 Heating to isomerize |
| 07/31/2007 | US7250512 An iridium complex of 2-(2-thienyl)-5-trifluoromethyl)pyridine compounds; light-emitting diodes |
| 07/26/2007 | WO2007059325A3 Drying methods of montelukast sodium by azeotropic removal of the solvent |
| 07/26/2007 | WO2007057225A3 Process for making montelukast and intermediates therefor |
| 07/26/2007 | WO2007025798A3 4-aryloxy quinoline derivatives as 5-ht6 modulators |
| 07/26/2007 | US20070173542 Peptide deformylase inhibitors |
| 07/26/2007 | US20070173498 Melanin concentrating hormone antagonist |
| 07/26/2007 | US20070173489 antagonists of the interaction between the plasma protein von Willebrand factor (vWF) and the blood platelet receptor glycoprotein Ib-IX-V complex, exhibit anticoagulant effect and are suitable for the therapy and prophylaxis of cardiovascular disorders |
| 07/25/2007 | EP1809608A1 Pyrimidine and quinoline potentiators of metabotropic glutamate receptors |
| 07/25/2007 | EP1809606A1 Compounds having activity at nk3 receptor and uses thereof in medicine |
| 07/25/2007 | EP1809605A1 Quinoline as allosteric enhancers of the gaba-b receptors |
| 07/25/2007 | EP1809288A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 07/25/2007 | EP1809284A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/25/2007 | EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2007 | EP1351940B1 Substituted quinolines for the treatment of protozoan and retrovirus co-infections |
| 07/25/2007 | EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands |
| 07/25/2007 | CN101006076A Modulators of ATP-binding cassette transporters |
| 07/25/2007 | CN101005839A Montelukast free acid polymorphs |
| 07/24/2007 | US7247756 1,4-disubstituted benzenes as insecticides |
| 07/24/2007 | CA2238274C Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 07/19/2007 | WO2007080140A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators |
| 07/19/2007 | WO2007079957A1 Substituted propiolic acid amides and their use for producing drugs |
| 07/19/2007 | WO2007026371A3 Process for preparing trandolapril and intermediates thereof |
| 07/19/2007 | US20070167626 Electron transport compound and organic light emitting device comprising the same |
| 07/19/2007 | US20070167452 Therapeutic amide derivatives |
| 07/19/2007 | US20070167444 Benzamide derivative or salt thereof |
| 07/19/2007 | US20070167427 1,2,4-Triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders |
| 07/19/2007 | US20070167423 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent |
| 07/19/2007 | US20070167410 cyclic oximes useful in treatment or prevention of diseases mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction; 3-{[5-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-5,6,7,8-tetrahydro-naphthalen-2-ylmethyl]-amino}-propionic acid |
| 07/19/2007 | US20070167350 Quinaldine based semisquaraines and squaraine dyes, process for preparation thereof and use thereof |
| 07/19/2007 | CA2635719A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators |
| 07/19/2007 | CA2633722A1 Substituted propiolic acid amides and their use for producing drugs |
| 07/18/2007 | EP1807391A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 07/18/2007 | EP1807080A1 Use of unsaturated quionoline or naphtalene derivatives as medicaments |
| 07/18/2007 | EP1663981B1 Piperazinyl-quinoline derivatives useful for the treatment of cns disorders |
| 07/18/2007 | EP1313707B1 Quinoline derivatives as anti-inflammation agents |
| 07/18/2007 | CN1326837C Process for preparing leukotrienes antagonist |
| 07/18/2007 | CN101001846A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 07/18/2007 | CN101001841A Tetrahydroquinolones and aza-analogues thereof for use as DPP-IV inhibitors in the treatement of diabetes |
| 07/18/2007 | CN101001629A Medicinal composition |
| 07/18/2007 | CN100999494A Compound with action of anti-HIV and malignant tumour and its preparation process and use |
| 07/18/2007 | CN100999493A Synthesizing process of quinolone main cycle compound |
| 07/18/2007 | CN100999492A Quinoline kind iriyellowsin electronic isostericmer its preparation process and use |
| 07/18/2007 | CN100999481A Selective androgen receptor modulators and methods of use thereof |
| 07/17/2007 | US7244763 Compounds that modulate PPAR activity and methods of preparation |
| 07/17/2007 | US7244725 treatment of Alzheimer's disease and more specifically compounds that are capable of inhibiting beta-secretase |
| 07/17/2007 | CA2373944C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 07/17/2007 | CA2303389C Antimicrobial quinolones, their compositions and uses |
| 07/12/2007 | WO2006058201A3 Heterocyclic and bicyclic compounds, compositions and methods |
| 07/12/2007 | US20070161796 Drying methods of montelukast sodium by azeotropic removal of the solvent |
| 07/12/2007 | US20070161697 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 07/12/2007 | US20070161651 Tie-2 modulators and methods of use |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161574 Hcv ns-3 serine protease inhibitors |
| 07/11/2007 | EP1806605A1 Filter and cyanine compound |
| 07/11/2007 | EP1805166A1 Quinoline derivatives |
| 07/11/2007 | EP1804781A1 Novel cyclic and acyclic propenones for treating cns disorders |
| 07/11/2007 | EP1664024B1 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors |
| 07/11/2007 | EP1572657B1 Processes for preparing quinolonecarboxylate derivatives |
| 07/11/2007 | CN1997628A Thio-substituted biaryl-methanesulfinyl derivatives |
| 07/11/2007 | CN1997625A 组蛋白脱乙酰基酶抑制剂 Histone deacetylase inhibitors |
| 07/11/2007 | CN1997278A Substituted organosulfur compounds and methods of using thereof |
| 07/11/2007 | CN1995018A 6-aryloxy-7-chloro-4-hydroxy-3-quinolinecarboxylate synthesis and uses |
| 07/11/2007 | CN1325475C Quinoline derivatives and their use as mycobacterial inhibitors |
| 07/11/2007 | CN1325472C Phenyl-substituted cyclic enaminones |
| 07/10/2007 | US7241894 Antitumor agents |
| 07/10/2007 | US7241810 For therapy of inflammatory, allergic and respiratory diseases |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241776 Amidomethyl-substituted, e.g., N-2-(4-chlorophenyl)-N-(1-{[N-cyano-2-(2-methylphenyl) ethanimidoyl]amino}-2,2-dimethylpropyl)acetamide; useful for treating pain, inflammation and neurodegeneration states |
| 07/10/2007 | US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 07/10/2007 | US7241764 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/05/2007 | WO2007075946A1 Compounds useful in cftr assays and methods therewith |
| 07/05/2007 | WO2007075194A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | WO2007041564A3 (s)-6-methyloxaalkyl exemestane compounds and related methods of use |
| 07/05/2007 | WO2007014940A8 Quinoline derivatives as antibacterical agents |
| 07/05/2007 | US20070155970 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
| 07/05/2007 | US20070155790 Meta-benzamidine derivatives as serine protease inhibitors |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155787 Amine salt of carbostyril derivative |
| 07/05/2007 | US20070155785 Hydroxamic acid compounds and methods of use thereof |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | CA2642130A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | CA2635214A1 Compounds useful in cftr assays and methods therewith |
| 07/05/2007 | CA2634113A1 Quinolin- 4 - one derivatives as modulators of abc transporters |
| 07/04/2007 | EP1802581A1 4 [(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 07/04/2007 | EP1251124B1 Process for the preparation of quinolylpropenal |
| 07/04/2007 | CN1993330A Quinoline derivatives as neurokinin receptor antagonists |
| 07/04/2007 | CN1993329A Quinoline derivatives as neurokinin receptor antagonists |
| 07/04/2007 | CN1993328A Quinoline derivative and insecticide containing same as active constituent |
| 07/04/2007 | CN1993326A Heterocyclic acetophenone potentiators of metabotropic glutamate receptors |
| 07/04/2007 | CN1324012C TNF-alpha prodn. inhibitors |
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 07/03/2007 | US7238707 Substituted pentanols, a process for their production and their use as anti-inflammatory agents |
| 06/28/2007 | WO2007073021A1 Novel quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease |
| 06/28/2007 | WO2007072114A1 An improved process for the manufacture of montelukast sodium |